Galephar Pharmaceutical Research Inc.

FDA inspection history in Juncos, Puerto Rico, 2021 to 2024

2
Form 483s

Every document, by year

  • Form 483

2021: one Form 483; 2024: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2021One Form 483, at Juncos, Puerto Rico.
  2. 2021The longest 483 on file: 2 observations over 4 pages at Juncos, Puerto Rico.
  3. 2024One Form 483, at Juncos, Puerto Rico.

Cited most

Across all Galephar Pharmaceutical Research observations on file

The complete Galephar Pharmaceutical Research file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2024-10-18483 Form 483$99
2021-06-09483 Form 483$99

FEI number 3003068480 · most recent document Oct 18, 2024

About Galephar Pharmaceutical Research Inc.

How many FDA Form 483s has Galephar Pharmaceutical Research Inc. received?

FDA Intel has 2 Form 483s on file for Galephar Pharmaceutical Research Inc.; the most recent is dated Oct 18, 2024.

When was Galephar Pharmaceutical Research Inc. last inspected by FDA?

The most recent FDA inspection document on file for Galephar Pharmaceutical Research Inc. is a Form 483 dated Oct 18, 2024, for the site in Juncos, Puerto Rico.

What did FDA cite at Galephar Pharmaceutical Research Inc.?

The regulations cited most in the observations on file for Galephar Pharmaceutical Research Inc. are 21 CFR 211.165 (Testing and release for distribution), 1 time; 21 CFR 211.166 (Stability testing), 1 time; 21 CFR 211.188(b)(12) (Batch production and control records), 1 time.